GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Oct 26, 2026
Buy
Calculated transaction value
$41.19K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Oct 22, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 4 days later
GRCE daily price context
Close on/before transaction
$1.92
Oct 22, 2026
First close after public filing
$1.87
Oct 27, 2026
Return after filing · so far
-0.37%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 21,390 shares @ $1.93
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-048591
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$158.6K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE | Buy | Oct 26, 2026 | $117.41K |
| Grace Therapeutics, Inc. GRCE Current | Buy | Oct 22, 2026 | $41.19K |